Stock Events

Stock Events

Stoke Therapeutics (STOK) Q4 2024 Earnings

5NovConfirmed

Q3 2023

Q2 2024

Q3 2024

Q4 2024

-0.63

-0.57

-0.52

-0.46

Details

Expected EPS

-0.52

Actual EPS

-0.47

Surprise EPS

0.05

Surprise Percent

+9.62%

Description

Stoke Therapeutics (STOK) has reported earnings of -0.47 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.